Evidence map›Paper›PMID 34624906›Full record

ArticlePlanta medica2022

Medicinal Plants for the Treatment of Mental Diseases in Pregnancy: An In Vitro Safety Assessment.

Deborah Spiess, Moritz Winker, Antoine Chauveau, Vanessa Fabienne Abegg, Olivier Potterat, Matthias Hamburger, Carsten Gründemann, Ana Paula Simões-Wüst

Open access · hybridAbstract read
In one paragraph

Article in Planta medica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. AdvancedFrontiers in pharmacology · 2022
    Article
  5. St. John's Wort usage in treating of perinatal depression.Frontiers in behavioral neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Deborah SpiessDepartment of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-8887-6194
Moritz WinkerCenter for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Antoine ChauveauDivision of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Vanessa Fabienne AbeggDivision of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Olivier PotteratDivision of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID 0000-0001-5962-6516
Matthias HamburgerDivision of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID 0000-0001-9331-273X
Carsten GründemannCenter for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Ana Paula Simões-WüstDepartment of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-4489-0952
University of Basel · CHUniversity of Freiburg · DEUniversity of Zurich · CH

Funding

Sinergia CRSII5_177260 Swiss National Science Foundation
6 · The paper itself

Abstract

Pregnancy is a critical period for medical care, during which the well-being of woman and fetus must be considered. This is particularly relevant in managing non-psychotic mental disorders since treatment with central nervous system-active drugs and untreated NMDs may have negative effects. Some well-known herbal preparations (phytopharmaceuticals), including St. John's wort, California poppy, valerian, lavender, and hops, possess antidepressant, sedative, anxiolytic, or antidepressant properties and could be used to treat mental diseases such as depression, restlessness, and anxiety in pregnancy. Our goal was to assess their safety

Indexed as

Anti-Anxiety AgentsHypericumMental DisordersOils, VolatilePlants, MedicinalValerianAntidepressive AgentsFemaleGlucoseHumansHypnotics and SedativesLactatesPhytotherapyPlacentaPlant ExtractsPregnancyAnti-Anxiety AgentsAntidepressive AgentsGlucoseHypnotics and SedativesLactatesOils, VolatilePlant Extracts

Identifiers

PMID34624906
PMCPMC9519192
OpenAlexW3203733539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.